vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $397.6M, roughly 1.2× Guardian Pharmacy Services, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 5.3%, a 1.6% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
GRDN vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $397.6M | $493.8M |
| Net Profit | $20.9M | $33.7M |
| Gross Margin | 21.5% | — |
| Operating Margin | 7.7% | 9.9% |
| Net Margin | 5.3% | 6.8% |
| Revenue YoY | — | -1.7% |
| Net Profit YoY | — | 10.5% |
| EPS (diluted) | — | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $397.6M | $493.8M | ||
| Q3 25 | $377.4M | $492.9M | ||
| Q2 25 | $344.3M | $468.8M | ||
| Q1 25 | $329.3M | $458.4M | ||
| Q4 24 | — | $502.4M | ||
| Q3 24 | $314.4M | $511.2M | ||
| Q2 24 | — | $504.3M | ||
| Q1 24 | — | $495.1M |
| Q4 25 | $20.9M | $33.7M | ||
| Q3 25 | $9.8M | $71.7M | ||
| Q2 25 | $9.0M | $39.3M | ||
| Q1 25 | $9.4M | $20.7M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $-122.0M | $19.4M | ||
| Q2 24 | — | $-153.0M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | 21.5% | — | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 19.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 7.7% | 9.9% | ||
| Q3 25 | 4.3% | 13.8% | ||
| Q2 25 | 3.7% | 12.8% | ||
| Q1 25 | 3.9% | 7.0% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | -33.3% | 6.6% | ||
| Q2 24 | — | -31.3% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | 5.3% | 6.8% | ||
| Q3 25 | 2.6% | 14.5% | ||
| Q2 25 | 2.6% | 8.4% | ||
| Q1 25 | 2.9% | 4.5% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | -38.8% | 3.8% | ||
| Q2 24 | — | -30.3% | ||
| Q1 24 | — | 0.8% |
| Q4 25 | — | $0.40 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | — | $0.23 | ||
| Q2 24 | — | $-1.84 | ||
| Q1 24 | — | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $375.2M |
| Total DebtLower is stronger | $0 | $570.5M |
| Stockholders' EquityBook value | $217.9M | $865.9M |
| Total Assets | $412.7M | $2.2B |
| Debt / EquityLower = less leverage | 0.00× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $375.2M | ||
| Q3 25 | $36.5M | $340.1M | ||
| Q2 25 | $18.8M | $224.7M | ||
| Q1 25 | $14.0M | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | $37.2M | $103.8M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $8.0M |
| Q4 25 | $0 | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $217.9M | $865.9M | ||
| Q3 25 | $195.5M | $890.7M | ||
| Q2 25 | $179.7M | $833.8M | ||
| Q1 25 | $163.2M | $789.2M | ||
| Q4 24 | — | $764.9M | ||
| Q3 24 | $133.9M | $732.5M | ||
| Q2 24 | — | $706.5M | ||
| Q1 24 | — | $856.2M |
| Q4 25 | $412.7M | $2.2B | ||
| Q3 25 | $390.0M | $2.2B | ||
| Q2 25 | $356.3M | $2.1B | ||
| Q1 25 | $334.0M | $2.0B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | $348.0M | $2.1B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | 0.00× | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.6M | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.65× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.6M | $114.1M | ||
| Q3 25 | $28.2M | $137.3M | ||
| Q2 25 | $19.9M | $137.2M | ||
| Q1 25 | $17.6M | $-117.5M | ||
| Q4 24 | — | $133.0M | ||
| Q3 24 | — | $91.8M | ||
| Q2 24 | — | $107.0M | ||
| Q1 24 | — | $-125.2M |
| Q4 25 | — | — | ||
| Q3 25 | $24.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 1.65× | 3.39× | ||
| Q3 25 | 2.87× | 1.91× | ||
| Q2 25 | 2.21× | 3.49× | ||
| Q1 25 | 1.86× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRDN
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
